Inhibition of AMPK catabolic action by GSK3
- PMID: 23623684
- PMCID: PMC3654099
- DOI: 10.1016/j.molcel.2013.03.022
Inhibition of AMPK catabolic action by GSK3
Abstract
AMP-activated protein kinase (AMPK) regulates cellular energy homeostasis by inhibiting anabolic and activating catabolic processes. While AMPK activation has been extensively studied, mechanisms that inhibit AMPK remain elusive. Here we report that glycogen synthase kinase 3 (GSK3) inhibits AMPK function. GSK3 forms a stable complex with AMPK through interactions with the AMPK β regulatory subunit and phosphorylates the AMPK α catalytic subunit. This phosphorylation enhances the accessibility of the activation loop of the α subunit to phosphatases, thereby inhibiting AMPK kinase activity. Surprisingly, PI3K-Akt signaling, which is a major anabolic signaling and normally inhibits GSK3 activity, promotes GSK3 phosphorylation and inhibition of AMPK, thus revealing how AMPK senses anabolic environments in addition to cellular energy levels. Consistently, disrupting GSK3 function within the AMPK complex sustains higher AMPK activity and cellular catabolic processes even under anabolic conditions, indicating that GSK3 acts as a critical sensor for anabolic signaling to regulate AMPK.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3.Biochem Pharmacol. 2006 May 28;71(11):1637-47. doi: 10.1016/j.bcp.2006.03.005. Epub 2006 Mar 10. Biochem Pharmacol. 2006. PMID: 16620785 Free PMC article.
-
AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.Mol Endocrinol. 2010 Jun;24(6):1218-29. doi: 10.1210/me.2009-0474. Epub 2010 Apr 2. Mol Endocrinol. 2010. PMID: 20363874 Free PMC article.
-
GSK3 and its interactions with the PI3K/AKT/mTOR signalling network.Adv Biol Regul. 2017 Aug;65:5-15. doi: 10.1016/j.jbior.2017.06.003. Epub 2017 Jun 27. Adv Biol Regul. 2017. PMID: 28712664 Review.
-
Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.FASEB J. 2016 Aug;30(8):2926-44. doi: 10.1096/fj.201600330RR. Epub 2016 May 10. FASEB J. 2016. PMID: 27166089 Free PMC article.
-
AMPKβ subunits: more than just a scaffold in the formation of AMPK complex.FEBS J. 2013 Aug;280(16):3723-33. doi: 10.1111/febs.12364. Epub 2013 Jun 24. FEBS J. 2013. PMID: 23721051 Review.
Cited by
-
Inhibition of glycogen synthase kinase-3β enhances cognitive recovery after stroke: the role of TAK1.Learn Mem. 2015 Jun 15;22(7):336-43. doi: 10.1101/lm.038083.115. Print 2015 Jul. Learn Mem. 2015. PMID: 26077686 Free PMC article.
-
Nutrient Excess and AMPK Downregulation in Incubated Skeletal Muscle and Muscle of Glucose Infused Rats.PLoS One. 2015 May 21;10(5):e0127388. doi: 10.1371/journal.pone.0127388. eCollection 2015. PLoS One. 2015. PMID: 25996822 Free PMC article.
-
CHIR99021, trough GSK-3β Targeting, Reduces Epithelioid Sarcoma Cell Proliferation by Activating Mitotic Catastrophe and Autophagy.Int J Mol Sci. 2021 Oct 15;22(20):11147. doi: 10.3390/ijms222011147. Int J Mol Sci. 2021. PMID: 34681807 Free PMC article.
-
Neurobiological Opportunities in Diabetic Polyneuropathy.Neurotherapeutics. 2021 Oct;18(4):2303-2323. doi: 10.1007/s13311-021-01138-y. Epub 2021 Dec 21. Neurotherapeutics. 2021. PMID: 34935118 Free PMC article. Review.
-
Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of salidroside on intestine ischemia reperfusion.Biosci Rep. 2023 Aug 31;43(8):BSR20230539. doi: 10.1042/BSR20230539. Biosci Rep. 2023. PMID: 37530723 Free PMC article.
References
-
- Carling D, Clarke PR, Zammit VA, Hardie DG. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur J Biochem. 1989;186:129–136. - PubMed
-
- Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol. 2001;2:769–776. - PubMed
-
- Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785–789. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
